Intec Pharma Ltd.
(NASDAQ : NTEC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
1.68%17.571.8%$88.82m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.50%183.766.2%$88.71m
SAGESAGE Therapeutics, Inc.
0.01%175.288.7%$77.73m
PRGOPerrigo Co. Plc
-0.57%47.506.8%$66.96m
ICPTIntercept Pharmaceuticals, Inc.
3.27%88.3118.6%$66.21m
JAZZJazz Pharmaceuticals Plc
-0.55%136.672.3%$59.25m
UTHRUnited Therapeutics Corporation
1.74%87.4914.3%$58.97m
ICLRICON Plc
1.80%141.014.1%$40.65m
ZYNEZynerba Pharmaceuticals Inc
-2.44%13.208.3%$40.52m
MDCOMedicines Company
2.43%35.0321.8%$39.73m
MNKMallinckrodt Plc
6.43%9.6921.0%$37.75m
CTLTCatalent Inc
0.26%46.312.4%$36.57m
AXSMAxsome Therapeutics, Inc.
4.67%24.672.1%$35.38m
HZNPHorizon Pharma plc
1.63%25.006.7%$34.77m
PCRXPacira Pharmaceuticals, Inc.
0.25%43.4410.5%$34.09m

Company Profile

Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which focuses on developing drugs based on its proprietary Accordion Pill platform technology. Its product pipeline includes four product candidates in clinical trial stages: Accordion Pill Carbidopa/Levodopa, which is being developed for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients; Accordion Pill Zaleplon, which is being developed for the treatment of insomnia, including sleep induction and the improvement of sleep maintenance; an Accordion Pill that is being developed for the prevention and treatment of gastroduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug which induces ulcers; and AP-CBD/THC, an Accordion Pill with the two primary cannabinoids contained in Cannabis sativa, cannabidiol and tetrahydrocannabinol, which is being developed for various indications including low back neuropathic pain and fibromyalgia. The company was founded by Zvi Joseph in 2000 and is headquartered in Jerusalem, Israel.